🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
COPD is a lung disease in which the lung is damaged, making it hard to brea...
Status
Unknown
Location
King Edward VII Hospital (Imperial College, London)
Start Date
2008-07
Trial ID
NCT00883584
This is a prospective interventional study to assess laboratory testing whi...
Status
Withdrawn
Location
University of Louisville
Start Date
2012-10
Trial ID
NCT01662258
Treatments Being Tested
The main reason for this study is to see if Acthar Gel can reduce inflammat...
Status
Terminated
Location
Blue Ocean Clinical Research
Start Date
2018-10-05
Trial ID
NCT03656692
Treatments Being Tested
This is a multicentric, prospective, intervention study on circadian genes ...
Status
Unknown
Location
Department of Experimental Medicine, "Sapienza" University of Rome
Start Date
2018-07-04
Trial ID
NCT04374721
Treatments Being Tested
Septic shock is a major cause of morbidity and mortality. SIRS (systemic in...
Status
Unknown
Location
St. Luke'S University Health Network
Start Date
2019-05-14
Trial ID
NCT03953404
Treatments Being Tested
The purpose of this study is to find out if 300 mg of BMS-582949 given once...
Status
Completed
Location
Desert Medical Advances
Start Date
2008-03
Trial ID
NCT00605735
Treatments Being Tested
ART is given to people living with HIV in order to suppress the virus, resu...
Status
Completed
Location
Desmond Tutu Health Foundation, University of Cape Town
Start Date
2022-03-02
Trial ID
NCT05333679
Treatments Being Tested
The purpose of this study is to determine if early diagnosis and risk strat...
Status
Completed
Location
Grey Nuns Community Hospital
Start Date
2011-11
Trial ID
NCT01634425
Treatments Being Tested
This small study is to investigate the efficacy of Acthar in the treatment ...
Status
Completed
Location
Clinvest/A Division of Banyan Group, Inc.
Start Date
2013-04
Trial ID
NCT01813591
Treatments Being Tested